Chow, Warren A. http://orcid.org/0000-0003-0889-5841
Yee, Jiing-Kuan
Tsark, Walter
Wu, Xiwei
Qin, Hanjun
Guan, Min
Ross, Jeffrey S.
Ali, Siraj M.
Millis, Sherri Z.
Funding for this research was provided by:
National Cancer Institute (P30CA033572)
Article History
Received: 18 February 2020
Accepted: 26 April 2020
First Online: 11 May 2020
Ethics approval and consent to participate
: Approval for this study, including a waiver of informed consent and a HIPAA waiver of authorization, was obtained by Foundation Medicine from the Western Institutional Review Board (Protocol No. 20152817). Additionally, next generation sequencing was performed at City of Hope (COH) on a single patient under a COH Investigational Review Board-approved protocol (COH IRB# 15243). Written consent was obtained from this patient.
: Not applicable.
: WAC is on the speaker’s bureau (Novartis), the data safety monitoring committee (Advenchen), and advisory board (GlaxoSmithKline). J-KY, WT, XW, HQ, and MG have nothing to disclose. JSR, SJA, and SZM are employees of Foundation Medicine.